{"altmetric_id":210520,"counts":{"readers":{"mendeley":28,"citeulike":4,"connotea":1},"policy":{"unique_users_count":3,"unique_users":["nap","nice","sign"],"posts_count":3},"total":{"posts_count":7},"f1000":{"unique_users_count":2,"unique_users":["F1000Prime","Nature clinical practice. Oncology"],"posts_count":2},"twitter":{"unique_users_count":2,"unique_users":["brownpa79","hswapnil"],"posts_count":2}},"selected_quotes":[".@hswapnil so very similar to TREAT and non CKD data #csn14"],"citation":{"abstract":"The erythropoiesis-stimulating agents (ESAs) erythropoietin and darbepoetin are licensed to treat chemotherapy-associated anemia in patients with nonmyeloid malignancies. Although systematic overviews of trials have identified venous thromboembolism (VTE) risks, none have identified mortality risks with ESAs.","abstract_source":"pubmed","altmetric_jid":"4f6fa4ee3cf058f610002c38","authors":["Charles L. Bennett","Samuel M. Silver","Benjamin Djulbegovic","Athena T. Samaras","C. Anthony Blau","Kara J. Gleason","Sara E. Barnato","Kathleen M. Elverman","D. Mark Courtney","June M. McKoy","Beatrice J. Edwards","Cara C. Tigue","Dennis W. Raisch","Paul R. Yarnold","David A. Dorr","Timothy M. Kuzel","Martin S. Tallman","Steven M. Trifilio","Dennis P. West","Stephen Y. Lai","Michael Henke"],"doi":"10.1001\/jama.299.8.914","handles":[],"isbns":[],"issns":["0098-7484","1538-3598"],"issue":"8","journal":"JAMA: Journal of the American Medical Association","last_mentioned_on":1398461383,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18314434","http:\/\/dx.doi.org\/10.1001\/jama.299.8.914"],"pdf_url":"http:\/\/jama.jamanetwork.com\/data\/journals\/jama\/4406\/jrv80002_914_924.pdf","pmid":"18314434","pubdate":"2008-02-27T00:00:00+00:00","publisher":"American Medical Association","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"914","subjects":["medicine"],"title":"Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.","type":"article","uri":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.299.8.914","volume":"299","mendeley_url":"http:\/\/www.mendeley.com\/research\/venous-thromboembolism-mortality-treatment-cancerassociated-anemia"},"altmetric_score":{"score":12.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":12.25},"context_for_score":{"all":{"total_number_of_other_articles":8398082,"mean":7.0731310424293,"rank":706643,"this_scored_higher_than_pct":91,"this_scored_higher_than":7688903,"rank_type":"exact","sample_size":8398082,"percentile":91},"similar_age_3m":{"total_number_of_other_articles":7763193,"mean":7.3974406823824,"rank":687038,"this_scored_higher_than_pct":91,"this_scored_higher_than":7072106,"rank_type":"exact","sample_size":7763193,"percentile":91},"this_journal":{"total_number_of_other_articles":20408,"mean":37.001193316019,"rank":6581,"this_scored_higher_than_pct":67,"this_scored_higher_than":13810,"rank_type":"exact","sample_size":20408,"percentile":67},"similar_age_this_journal_3m":{"total_number_of_other_articles":18558,"mean":40.032637064181,"rank":6270,"this_scored_higher_than_pct":66,"this_scored_higher_than":12270,"rank_type":"exact","sample_size":18558,"percentile":66}}},"demographics":{"poster_types":{"member_of_the_public":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1,"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":1,"Researcher":5,"Student  > Ph. D. Student":4,"Other":2,"Student  > Master":6,"Student  > Bachelor":4,"Lecturer > Senior Lecturer":1,"Professor":4},"by_discipline":{"Medicine and Dentistry":15,"Agricultural and Biological Sciences":9,"Mathematics":1,"Unspecified":2,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"CA":2},"mendeley":{"NL":1,"BR":1,"FR":1}}},"posts":{"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/1103240","license":"public","citation_ids":[210520],"posted_on":"2008-03-05T00:00:00+00:00","f1000_classes":["confirmation"],"f1000_score":"2"},{"title":"VTE and mortality associated with erythropoiesis-stimulating agents in cancer-associated anemia.","url":"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18648351","citation_ids":[210520],"posted_on":"2008-08-31T23:00:00+00:00"}],"twitter":[{"url":"http:\/\/twitter.com\/brownpa79\/status\/459806351984566272","license":"datasift","citation_ids":[210520],"posted_on":"2014-04-25T21:29:11+00:00","author":{"name":"Pierre Antoine Brown","image":"https:\/\/pbs.twimg.com\/profile_images\/668887816454152192\/WSSSjK2O_normal.jpg","description":"MD @uOttawaMedFR, MMI @NorthwesternU, Nephrologist @ottawarenal @uOttawaMed @ottawahospital, Francophone, Opinions my own, no medical advice here.","id_on_source":"brownpa79","tweeter_id":"2478764895","geo":{"lt":45.41117,"ln":-75.69812,"country":"CA"},"followers":627},"tweet_id":"459806351984566272"},{"url":"http:\/\/twitter.com\/hswapnil\/status\/459806485082406912","license":"datasift","rt":["brownpa79"],"citation_ids":[210520],"posted_on":"2014-04-25T21:29:43+00:00","author":{"name":"Swapnil Hiremath, MD","url":"http:\/\/about.me\/swapnil.hiremath","image":"https:\/\/pbs.twimg.com\/profile_images\/730502747754139649\/hP6Q9DDQ_normal.jpg","description":"Nephrologist, Mumbai|Boston now Ottawa. #NephJC cofounder. Work at @ottawahospital @uottawamed @ottawarenal Opinions personal etc\/No pharma conflicts","id_on_source":"hswapnil","tweeter_id":"23789628","geo":{"lt":45.41117,"ln":-75.69812,"country":"CA"},"followers":4004},"tweet_id":"459806485082406912"}],"policy":[{"title":"Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary","url":"https:\/\/www.nap.edu\/download\/13345","license":"public","citation_ids":[559645,14713888,458385,2079599,1438178,4818860,14713894,2849337,14713899,3554876,3977758,14713902,1040814,2428320,14713906,14713908,512483,3554904,14713909,14486624,1358387,208844,1068653,5767349,5785957,5730279,22794836,185476,5756689,14713910,184292,569443,6072995,137682,239754,8440489,14713912,211417,5593025,206101,14713913,531383,402771,587483,20480473,1205564,14713916,1202054,416930,5747899,5751144,210520,640440,478438,1384176,438574,5580865,181015,481163,1450694,401024,1457018,187544,573699,14713930,6259121,6259121,6259121],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/13345\/envisioning-a-transformed-clinical-trials-enterprise-in-the-united-states","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-760da04e528794fa9c24195cb9268fd92a13a2ec66648084409455b64007811a.jpg"}},{"title":"Erythropoiesis\u2011stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy: Anaemia (cancer-treatment induced) - erythropoiesis-stimulating agents (epoetin and darbepoetin) (inc rev TA142): evaluation report","url":"https:\/\/www.nice.org.uk\/guidance\/TA323\/documents\/anaemia-cancertreatment-induced-erythropoiesisstimulating-agents-epoetin-and-darbepoetin-inc-rev-ta142-evaluation-report2","license":"public","citation_ids":[20559817,542389,20543235,20559824,20559830,20559833,20559837,20559842,20559844,20559852,20559858,20559863,20559868,20559871,20559877,20559880,20328340,20559883,20559886,20559889,20559892,20559895,20559900,20559910,20559935,20559944,7853288,20559954,20559961,20559964,20559966,1068651,20559995,20559999,20560005,20560009,20560010,20560014,5730013,20560022,20520143,20560026,20560029,2826808,6091477,17960669,20560037,16024508,20560042,20560044,20560046,20560052,6079023,20560058,20560065,227780,20560073,20560077,1233878,20560085,4233141,20560094,20560098,20560103,20560105,20560110,5785950,20560116,20560117,3077914,817113,5793332,20560130,20560133,20560137,16685368,20560141,5582772,20560150,20560155,20560159,20560160,20560164,20560169,20560173,20560179,17965062,20560187,20560192,5314511,20560196,20560199,20560203,20560206,20560210,20560213,20560217,20560220,20560222,5785953,20560227,20560229,20560231,20558187,16685370,210520,5606480,20560242,20560246,5754844,5728047,20560256,210508,228589,20560264,20560268,20560273,20560275,20560278,20560281,17910642,537576,20560289,20560292,20560297,4323630,20560301,20560322,20560325,20560329,20560334,20560343,20560352,20560356,20560359,20560364,20560367,20560372,20560375,20560378,20560380,20560383,20560386,20560391,20560396,20560401,20560405,20560409,20560412,20560420,20560425,16685367,20560431,20560434,20560441,20560445,20560449,20560549,20560555,20560562,17903608,20560657,20560665,20560670,20560675,20560678,20560680,20560683,20560685,20560690,20560694,20560701,20560706,20560712,20560718,20560720,20560725,1428849,4273683,20560746,20560750,20560752,5778068,7742482,20560764,20560769,20520149,20560773,20560779,20560787,20560791,20560800,20560806,20560814,20560818,20560823,20560825,20560828,8064455,17909340,20560838,20560840,5381355,20560853,20560862,20560865,20560869,20560875,20560883,173734,20560890,20560920,20560927,5581930,20559817,20560014],"posted_on":"2014-04-15T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/ta323\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-1688c9323bc1c873924cb8dfd25b2b32ac683222fb2139083b9e2501db6832aa.jpg"}},{"title":"Prevention and management of venous thromboembolism","url":"http:\/\/www.sign.ac.uk\/pdf\/sign122.pdf","license":"public","citation_ids":[1522660,2413959,15634414,26304885,26304886,1075703,3913511,221652,220596,26304890,2045973,865943,12680166,26303963,26304899,716466,26304903,1501913,26304904,2418048,3253474,26304907,512122,20454920,16031544,26304911,26304918,1078049,230657,15787003,1077957,26304939,15787009,12487133,1781497,16031563,3594648,5798371,26304943,25238481,26304949,176494,26304951,26304953,132184,3724627,26304979,26304982,15781225,15787084,26304985,1157236,22046191,26304993,7386867,232221,5739480,26304997,2839298,2415358,26304523,26305008,3522270,2839296,3549629,26305012,3352177,210257,26305015,1358437,26305020,26305023,26305029,20523506,2417157,3109884,2631718,15787307,26305035,716415,5402403,26305043,26305045,25238477,5368255,26305051,26305053,26305055,540610,1830653,134068,18540794,26305058,26305062,26305064,4216833,563928,26305067,3817032,26305073,26305078,4438878,4216839,26305086,26305090,26305093,405827,26305100,26305102,3206765,26305104,26305108,1718908,26305111,26305114,15781126,26305115,3206760,26305120,15787271,26305124,2768246,26305129,26305135,26305139,9980552,590443,2206364,1469918,4023441,24721521,20558807,5756505,22424974,25238458,26305170,13671672,26304635,26305179,26305182,26305186,26305191,10950200,19608227,4216840,26305198,20560006,5584906,20558584,484014,20558737,20559510,3913554,3913595,15776420,20558293,5991247,531181,210360,226372,15776341,3253481,26305212,3244277,26305218,3209306,26305220,584001,26305223,26305227,26305230,26305237,21608995,20558820,26305240,26305244,26305248,5501280,20558546,5020618,26303956,26305280,3642049,20559075,15062433,3913490,26305282,3913553,26305283,20558402,26305286,20559859,532142,522350,540489,517169,1144007,26305290,26305295,26305299,20559103,7396941,26305306,26305310,26305315,26305323,26305327,20558837,3913549,26305328,20559111,221655,3913582,3913505,26305331,21608969,3212730,3913593,26305335,14822179,26305340,26305343,20559988,4293144,3913534,3913508,20558571,26305345,26305348,26305352,26305354,26305358,26305363,10838364,26305365,26305367,26305369,26305373,26305375,3257467,26305378,1798342,2362000,26305391,26305392,3045179,2177362,1345748,7409527,26305400,7411009,16223077,9761835,226346,1723108,26305429,2546127,9648198,26305444,22860836,13080936,517207,1125935,16776095,1075795,26305453,231810,26305457,4648201,210520,26305459,15254244,9761832,5402398,1430272,26305466,13011598,26305469,15680825,26305475,26305476,26305480,22452517,15358688,26305490,26305492,5000803,26305494,22452433,5000802,8113207,26305500,5402445,26305506,15638591,20559101,26305511,536308,5582319,1525226,8810213],"posted_on":"2010-01-01T00:00:00+00:00","source":{"name":"Scottish Intercollegiate Guidelines Network","description":"The Scottish Intercollegiate Guidelines Network (SIGN) develops evidence based clinical practice guidelines for the National Health Service (NHS) in Scotland.","geo":{"country":"GB"}},"page_url":"http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/122\/index.html","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-669ea6bc81da8a58a6b1d0c27ddb8f43724c5b9dc2716af8cb51720cb462373d.jpg"}}]}}